Abstract
A novel set of acridinylidene thiazolidinediones and benzylidene thiazolidinediones was synthesized by nucleophilic addition of cyanoacrylates. Some of these compounds were evaluated for their glucose lowering capability and their effects on the triglyceride level in alloxan diabetic mice.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acridines / chemical synthesis*
-
Acridines / chemistry
-
Acridines / pharmacology
-
Animals
-
Benzyl Compounds / chemical synthesis*
-
Benzyl Compounds / chemistry
-
Benzyl Compounds / pharmacology
-
Blood Glucose / drug effects
-
Body Weight / drug effects
-
Diabetes Mellitus, Experimental / blood
-
Diabetes Mellitus, Experimental / mortality
-
Drug Evaluation, Preclinical
-
Female
-
Hypoglycemic Agents / chemical synthesis*
-
Hypoglycemic Agents / pharmacology
-
Male
-
Mice
-
Rosiglitazone
-
Thiazolidinediones / chemical synthesis*
-
Thiazolidinediones / chemistry
-
Thiazolidinediones / pharmacology
-
Triglycerides / blood
Substances
-
3-benzyl-5-acridinylidene-thiazolidine-2,4-dione
-
5-benzylidene-3-(4-methyl-benzyl)-thiazolidine-2,4-dione
-
Acridines
-
Benzyl Compounds
-
Blood Glucose
-
Hypoglycemic Agents
-
Thiazolidinediones
-
Triglycerides
-
Rosiglitazone